PATRICIA DUFF: Open Payments
NPI 1043609647 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,715 in 48 payments from 13 companies in 2025. Trend: 2023 $891 · 2024 $1,008 · 2025 $1,715
Food & beverage: $1,715
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 23 | $1,078 |
| Boston Scientific Corporation | 4 | $157 |
| AstraZeneca Pharmaceuticals LP | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $84 |
| PFIZER INC. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| AtriCure, Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
Products named: SAPIEN 3 Ultra RESILIA, General - Vascular Intervention, LEQVIO, CAMZYOS, FARXIGA, VYNDAQEL, JARDIANCE, ELIQUIS.
Industry payments across MD — which companies pay providers there.
